Skip to main content
Premium Trial:

Request an Annual Quote

Dale Pfost, Donald Marvin, Klaus Schollmeier, Tristan Orpin


Dale Pfost has resigned as president and CEO of Orchid BioSciences of Princeton, N.J., and Donald Marvin has resigned as senior vice president and general manager, the company announced this week. Orchid has established a search committee to find a replacement for Pfost who is leaving to pursue other opportunities. Pfost was chairman of the company from November 1996 to September 2002.

Klaus Schollmeier has been appointed chief executive officer of Graffinity Pharmaceuticals of Heidelberg, Germany, effective Jan. 1, 2003. Schollmeier most recently served as managing director of the healthcare/biotechnology group at ING-BHF Bank and previously held senior management positions at BASF Pharma. Schollmeier holds a PhD in biology from the University of D sseldorf and has been an adjunct research associate professor at Boston University Medical School.

Tristan Orpin was named vice president of worldwide sales for San Diego-based Illumina, the company announced last week. Orpin, formerly vice president for sales and marketing for Sequenom, will head sales of BeadArray and Oligator technology for Illumina. Previously, Orpin worked in sales for Bio-Rad Laboratories where he was Australasian general manager for the company’s life sciences division. Orpin has a BS degree in biochemistry from the University of Melbourne, Australia.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.